CL-387785: covalent, irreversible inhibitor of EGF and related receptor tyrosine kinases April 14, 1999
Once-weekly administration of topoisomerase II inhibitor is associated with reduced toxicity April 14, 1999
Controlled-release formulation of paclitaxel endowed with superior in vivo antitumor activity April 14, 1999
RSS